Skip to content

Outcomes in patients of acute pancreatitis undergoing percutaneous catheter drainage: a comparison of two different drainage strategies

Initial single vs multiple percutaneous catheter insertion for drainage in pancreatic necrotic collections: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044089
Enrollment
50
Registered
2022-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K859- Acute pancreatitis, unspecified

Interventions

Intervention1: Initial Multiple Catheter Insertion: In this group, patients will undergo initial multiple percutaneous catheter insertion for the necrotic pancreatic collection Control Intervention1:

Sponsors

Dr Prabhjyot Singh Chowhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients/Relatives of the patients (when the patient is not in a position to give consent or not oriented to time, place or person) who give informed consent for participation in the study. 2. Treatment-naive patients 3. Symptomatic necrotic pancreatic collections deemed suitable for percutaneous drainage by the treating clinician 4. Availability of a safe bowel-free approach

Exclusion criteria

Exclusion criteria: 1. Previous drainage or surgery for confirmed or suspected infected necrosis 2. Pancreatitis caused by abdominal surgery or endoscopy 3. Acute Pancreatic Fluid Collections and Pseudocysts 4. Coagulopathy or thrombocytopenia 5. Not willing to participate in the study 6. Underlying malignancy

Design outcomes

Primary

MeasureTime frame
1. Need for surgery 2. MortalityTimepoint: At the time of discharge or when shifted for surgery or death

Secondary

MeasureTime frame
1. Length of ICU and hospital stay 2. Organ failure reversal after PCD 3. Number of interventions required 4. Catheter related complications 5. Reduction in the levels of inflammatory markers 6. Number of total days of PCDTimepoint: At the time of discharge or when shifted for surgery or death

Countries

India

Contacts

Public ContactDr Mandeep Kang

Postgraduate Institute of Medical Education and Research, Chandigarh

drmkang@gmail.com9888188230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026